
zzso are the most important causes of morbidity and mortality in patients with aggressive zzso and those undergoing zzso stem cell zzso The introduction of new therapeutic approaches including the use of zzso zzso and of zzso zzso to zzso and zzso and the increased use of matched unrelated stem cell donors has resulted in new challenges with regard to systemic viral and zzso zzso In patients with bacterial infections, emergence of resistance to formerly widely used antibiotics as well as a shift of zzso pathogens towards a predominance of zzso zzso zzso has to be taken into zzso In high-risk zzso patients with fever of unknown origin, prompt zzso zzso with zzso zzso zzso or a zzso is zzso In patients with lung zzso early zzso intervention with an zzso active against zzso is recommended, whereas in patients with zzso skin or soft tissue infections, zzso addition of a zzso shows a high response zzso The prompt zzso use of zzso or zzso in zzso stem cell transplant recipients can reliably be guided by serial monitoring of zzso zzso and zzso chain reaction zzso 

